Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Medenvision is active in the Medical Devices & Mechanical Engineering technology area. The portfolio currently contains 2 pending office actions. These 2 actions are handled by 1 distinct examiner. This concentration is further reflected in the administrative structure, as all pending work is located within 1 distinct art unit. This indicates a high level of focus for the company's current prosecution efforts, with no variation in the examiner or the art unit assigned to the pending matters.
The busiest examiner for Medenvision is MILLER, DANIEL A, who is responsible for 2 pending office actions. This examiner manages the company's current pending workload. Because the actions are assigned to this 1 individual within the 1 distinct art unit, the outcomes for the portfolio are currently dependent on this examiner's interpretations. This centralized arrangement in the Medical Devices & Mechanical Engineering sector simplifies the point of contact for the legal team. However, it also increases the influence of the examiner's decision-making on the company's patent prospects across the 2 pending actions.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MILLER, DANIEL A | 2 | 34.3% | +57.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18439586 | SURGICAL DRAPE | MILLER, DANIEL A | 194d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18439586 | SURGICAL DRAPE | MILLER, DANIEL A | 194d overdue |
| 19052171 | SURGICAL DRAPE | MILLER, DANIEL A | 36d overdue |
| Art Unit | Apps |
|---|---|
| 3786 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19052171 | SURGICAL DRAPE | MILLER, DANIEL A | 3786 | §103 | Final Rejection | 36d overdue | Pending | Feb 12, 2025 |
| 18439586 | SURGICAL DRAPE | MILLER, DANIEL A | 3786 | §103§112 | Non-Final OA | 194d overdue | Pending | Feb 12, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial